Skip to main content
Diasorin logo

Diasorin — Investor Relations & Filings

Ticker · DIA ISIN · IT0003492391 LEI · 8156002878BDF0EE4348 XMIL Manufacturing
Open in API
Filings indexed 817 across all filing types
Latest filing 2021-03-19 AGM Information
Country IT Italy
Listing XMIL DIA

About Diasorin

https://diasoringroup.com/en

Diasorin is a global leader in the In Vitro Diagnostic (IVD) field, developing, producing, and marketing reagent kits for laboratory diagnostics. The company specializes in immunodiagnostics and molecular diagnostics. Its immunodiagnostics technology is based on detecting antibodies and antigens in fluid samples to identify diseases or measure physiological markers. The molecular diagnostics division provides flexible tools using targeted and multiplex technologies to detect pathogens in biological specimens. Since 2021, Diasorin has also been active in the Life Science business, offering platforms for biomedical research, clinical diagnostics, and drug discovery. Through its product lines, such as the LIAISON® family of analyzers and assays, the company aims to empower healthcare providers with actionable information to improve patient care, enable faster triage, and reduce unnecessary antibiotic use.

Recent filings

Filing Released Lang Actions
Assemblea degli Azionisti 22 aprile 2021 - Modulo delega SPAFID (art. 135-novies TUF)
AGM Information Classification · 98% confidence The document is titled "CONFERIMENTO DELEGA/SUBDELEGA AL RAPPRESENTANTE DESIGNATO AI SENSI DELL'ART. 135-NOVIES DEL D. LGS. 58/1998 ("TUF")" and contains a detailed voting instruction form for an upcoming shareholder meeting (Assemblea ordinaria e straordinaria di DiaSorin S.p.A. convocata per il giorno 22 aprile 2021). This form is used by shareholders to delegate their voting rights to a designated representative (Spafid) and provide specific voting instructions on agenda items, such as the approval of the 2020 financial statements (Item 1.1). This material is directly related to soliciting shareholder votes and providing necessary information for that purpose, which aligns perfectly with the definition of Proxy Solicitation & Information Statement (PSI). It is not the AGM presentation itself (AGM-R), nor the full Annual Report (10-K), but the mechanism for voting at the meeting.
2021-03-19 Italian
Shareholders' Meeting April 22, 2021 - Reports and motions for resolutions
AGM Information Classification · 100% confidence The document is explicitly titled 'SHAREHOLDERS' MEETING DIASORIN S.p.A.' and details the 'Notice of Shareholders' Meeting' for April 22/23, 2021. It outlines the agenda for both Ordinary and Extraordinary parts, including items like approval of financial statements, remuneration policy, stock option plans, and amendments to bylaws. This content is characteristic of materials prepared to solicit shareholder votes and provide necessary information ahead of a general meeting. The most fitting category is 'Proxy Solicitation & Information Statement' (PSI), as it contains the notice, agenda, and instructions for voting/proxy submission, which are core components of proxy materials. It is not the AGM presentation itself (AGM-R) nor a general regulatory filing (RNS).
2021-03-19 English
Assemblea degli Azionisti 22 aprile 2021 - Relazioni illustrative e proposte di delibera
AGM Information Classification · 100% confidence The document is titled "ASSEMBLEA DEGLI AZIONISTI DIASORIN S.p.A." (Shareholders' Meeting of Diasorin S.p.A.) and contains "RELAZIONI ILLUSTRATIVE E PROPOSTE DI DELIBERA SUGLI ARGOMENTI ALL'ORDINE DEL GIORNO" (Explanatory Reports and Proposals for Resolutions on the Agenda Items). It explicitly details the agenda for the Ordinary and Extraordinary Shareholders' Meeting scheduled for April 22/23, 2021, including items like the approval of the 2020 Financial Statements, remuneration policy, stock option plans, and amendments to the Bylaws. It also provides extensive instructions on how shareholders can attend and vote via a designated representative due to COVID-19 measures, referencing Italian regulations (TUF, Decreto Legge). This content is characteristic of the preparatory materials distributed before a general meeting to inform shareholders and solicit their votes. This aligns perfectly with the definition of Proxy Solicitation & Information Statement (PSI), which covers materials sent to shareholders to provide information and request votes for meetings. While it discusses AGM topics, it is the solicitation document, not the AGM presentation (AGM-R) or the final voting results (DVA).
2021-03-19 Italian
DiaSorin S.p.A. - Dividend coupon date correction
Notice of Dividend Amount Classification · 98% confidence The document is a short regulatory announcement from DiaSorin dated March 11, 2021. The subject line explicitly states 'DiaSorin S.p.A. - Dividend coupon date correction'. The body of the text corrects the dividend coupon date, payment date, and record date. This content directly relates to the announcement of dividend details. Based on the definitions, the most appropriate code is 'DIV' (Notice of Dividend Amount). Although the text mentions 'Vedi allegato' (See attachment), the core content is the dividend correction itself, making DIV more specific than RPA or RNS, especially since the length is short and the topic is highly specific.
2021-03-11 English
DiaSorin S.p.A. - Rettifica data stacco dividendo
Notice of Dividend Amount Classification · 98% confidence The document is a short regulatory announcement (length 1805 chars) from DiaSorin, dated March 11, 2021. The subject line ('Oggetto') explicitly states 'DiaSorin S.p.A. - Rettifica data stacco dividendo' (DiaSorin S.p.A. - Dividend Ex-Date Correction). The body confirms this correction regarding the dividend ex-coupon date, payment date, and record date. This directly corresponds to the definition of a dividend announcement, specifically a correction to one. The closest matching code is 'DIV' (Notice of Dividend Amount). Although it is a correction, the core subject is the dividend detail.
2021-03-11 Italian
DiaSorin – Revenues, Profitability and Cash Flow Generation hit record highs in 2020
Earnings Release Classification · 95% confidence The document is an official press release from DiaSorin S.p.A. dated March 11, 2021, announcing their full-year 2020 financial results. It provides key financial highlights (Revenues, EBITDA, EBIT, Net Profit), business development updates, and guidance. While it contains financial data, it is structured as a summary announcement (Earnings Release) rather than the full audited Annual Report (10-K) or a comprehensive Interim Report (IR). It follows the standard format for an initial earnings announcement. FY 2020
2021-03-11 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.